Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Rheumatoid Arthritis

  Free Subscription

Articles published in PLoS One

Retrieve available abstracts of 69 articles:
HTML format

Single Articles

    January 2022
  1. YANAGISAWA S, Nagasaki K, Chea C, Ando T, et al
    Oral administration of bovine lactoferrin suppresses the progression of rheumatoid arthritis in an SKG mouse model.
    PLoS One. 2022;17:e0263254.
    PubMed     Abstract available

  2. LIU C, Fan F, Zhong L, Su J, et al
    Elucidating the material basis and potential mechanisms of Ershiwuwei Lvxue Pill acting on rheumatoid arthritis by UPLC-Q-TOF/MS and network pharmacology.
    PLoS One. 2022;17:e0262469.
    PubMed     Abstract available

  3. NGUYEN THP, Hokstad I, Fagerland MW, Mollnes TE, et al
    Antirheumatic therapy is associated with reduced complement activation in rheumatoid arthritis.
    PLoS One. 2022;17:e0264628.
    PubMed     Abstract available

  4. HU J, Zhao L, Li N, Yang Y, et al
    Investigation of the active ingredients and pharmacological mechanisms of Porana sinensis Hemsl. Against rheumatoid arthritis using network pharmacology and experimental validation.
    PLoS One. 2022;17:e0264786.
    PubMed     Abstract available

  5. YASUDA T, Tahara K, Sawada T
    Detection of salivary citrullinated cytokeratin 13 in healthy individuals and patients with rheumatoid arthritis by proteomics analysis.
    PLoS One. 2022;17:e0265687.
    PubMed     Abstract available

  6. WHITE IR, Kleinstein SE, Praet C, Chamberlain C, et al
    A genome-wide screen for variants influencing certolizumab pegol response in a moderate to severe rheumatoid arthritis population.
    PLoS One. 2022;17:e0261165.
    PubMed     Abstract available

  7. SHIRAISHI K, Chiba K, Watanabe K, Oki N, et al
    Analysis of bone erosions in rheumatoid arthritis using HR-pQCT: Development of a measurement algorithm and assessment of longitudinal changes.
    PLoS One. 2022;17:e0265833.
    PubMed     Abstract available

  8. NAM SH, Ahn SM, Oh JS, Hong S, et al
    Macrophage activation syndrome in rheumatic disease: Clinical characteristics and prognosis of 20 adult patients.
    PLoS One. 2022;17:e0267715.
    PubMed     Abstract available

  9. GENC D, Bulut O, Gunaydin B, Goksu M, et al
    Dental follicle mesenchymal stem cells ameliorated glandular dysfunction in Sjogren's syndrome murine model.
    PLoS One. 2022;17:e0266137.
    PubMed     Abstract available

  10. GHOURI M, Ismail M, Zaidi SA, Rehman S, et al
    Multi-locus SNP analyses of interleukin 1 receptor associated kinases 2 gene polymorphisms with the susceptibility to rheumatoid arthritis.
    PLoS One. 2022;17:e0268496.
    PubMed     Abstract available

  11. DESSIE G
    Association of atherogenic indices with C-reactive protein and risk factors to assess cardiovascular risk in rheumatoid arthritis patient at Tikur Anbessa Specialized Hospital, Addis Ababa.
    PLoS One. 2022;17:e0269431.
    PubMed     Abstract available

  12. LI Z, Mu Y, Guo C, You X, et al
    Analysis of the saliva metabolic signature in patients with primary Sjogren's syndrome.
    PLoS One. 2022;17:e0269275.
    PubMed     Abstract available

  13. MORI S, Okada A, Koga T, Ueki Y, et al
    Long-term outcomes after discontinuing biological drugs and tofacitinib in patients with rheumatoid arthritis: A prospective cohort study.
    PLoS One. 2022;17:e0270391.
    PubMed     Abstract available

  14. MIKAMI S, Miura Y, Kondo S, Sakai K, et al
    Nintedanib induces gene expression changes in the lung of induced-rheumatoid arthritis-associated interstitial lung disease mice.
    PLoS One. 2022;17:e0270056.
    PubMed     Abstract available

  15. GONI M, Basu N, Murray AD, Waiter GD, et al
    Brain predictors of fatigue in rheumatoid arthritis: A machine learning study.
    PLoS One. 2022;17:e0269952.
    PubMed     Abstract available

  16. WAKI D, Tamai H, Yokochi R, Kido T, et al
    Effects of anti-SSA antibodies on the response to methotrexate in rheumatoid arthritis: A retrospective multicenter observational study.
    PLoS One. 2022;17:e0271921.
    PubMed     Abstract available

  17. MOVAHEDI M, Cesta A, Li X, Bombardier C, et al
    Disease activity trajectories for early and established rheumatoid arthritis: Real-world data from a rheumatoid arthritis cohort.
    PLoS One. 2022;17:e0274264.
    PubMed     Abstract available

  18. TEMMOKU J, Miyata M, Suzuki E, Sumichika Y, et al
    Comparing the effectiveness and safety of Abatacept and Tocilizumab in elderly patients with rheumatoid arthritis.
    PLoS One. 2022;17:e0274775.
    PubMed     Abstract available

  19. SANTOS IA, Donizeti Ribeiro de Oliveira R, Couto Luna Almeida S, Vargas-Santos AB, et al
    Comparison of rheumatoid arthritis composite disease activity indices and residual activity in a Brazilian multicenter study- REAL study.
    PLoS One. 2022;17:e0273789.
    PubMed     Abstract available

  20. SCRIVO R, Molteni E, Castellani C, Altobelli A, et al
    Are interferon-gamma release assays reliable to detect tuberculosis infection in patients with rheumatoid arthritis treated with Janus kinase inhibitors?
    PLoS One. 2022;17:e0275329.
    PubMed     Abstract available

  21. VALLEJO-YAGUE E, Pfund JN, Burkard T, Clair C, et al
    Lower odds of remission among women with rheumatoid arthritis: A cohort study in the Swiss Clinical Quality Management cohort.
    PLoS One. 2022;17:e0275026.
    PubMed     Abstract available

  22. REITER MP, Ward SH, Perry B, Mann A, et al
    Intra-articular injection of epigallocatechin (EGCG) crosslinks and alters biomechanical properties of articular cartilage, a study via nanoindentation.
    PLoS One. 2022;17:e0276626.
    PubMed     Abstract available

  23. JUNG N, Park S, Kong T, Park H, et al
    LC-MS/MS-based serum proteomics reveals a distinctive signature in a rheumatoid arthritis mouse model after treatment with mesenchymal stem cells.
    PLoS One. 2022;17:e0277218.
    PubMed     Abstract available

  24. TANAKA E, Inoue E, Shoji A, Nilsson J, et al
    Cost-consequence of abatacept as first-line therapy in Japanese rheumatoid arthritis patients using IORRA real-world data.
    PLoS One. 2022;17:e0277566.
    PubMed     Abstract available

  25. LI Y, Li Z, Sun W, Wang M, et al
    Characteristics of gut microbiota in patients with primary Sjogren's syndrome in Northern China.
    PLoS One. 2022;17:e0277270.
    PubMed     Abstract available

  26. DISSANAYAKE K, Jayasinghe C, Wanigasekara P, Dissanayake J, et al
    Validity of clinical disease activity index (CDAI) to evaluate the disease activity of rheumatoid arthritis patients in Sri Lanka: A prospective follow up study based on newly diagnosed patients.
    PLoS One. 2022;17:e0278285.
    PubMed     Abstract available

    January 2021
  27. PAGLIA MDG, Silva MT, Lopes LC, Barberato-Filho S, et al
    Use of corticoids and non-steroidal anti-inflammatories in the treatment of rheumatoid arthritis: Systematic review and network meta-analysis.
    PLoS One. 2021;16:e0248866.
    PubMed     Abstract available

  28. KUR-ZALEWSKA J, Kisiel B, Kania-Pudlo M, Tlustochowicz M, et al
    A dose-dependent beneficial effect of methotrexate on the risk of interstitial lung disease in rheumatoid arthritis patients.
    PLoS One. 2021;16:e0250339.
    PubMed     Abstract available

  29. DONNELLY S, Wilson AG, Mannan H, Dix C, et al
    Correction: (In)Visible illness: A photovoice study of the lived experience of self-managing rheumatoid arthritis.
    PLoS One. 2021;16:e0250451.
    PubMed     Abstract available

  30. LIN CT, Huang WN, Tsai WC, Chen JP, et al
    Predictors of drug survival for biologic and targeted synthetic DMARDs in rheumatoid arthritis: Analysis from the TRA Clinical Electronic Registry.
    PLoS One. 2021;16:e0250877.
    PubMed     Abstract available

  31. TATANGELO M, Tomlinson G, Paterson JM, Keystone E, et al
    Health care costs of rheumatoid arthritis: A longitudinal population study.
    PLoS One. 2021;16:e0251334.
    PubMed     Abstract available

  32. KATO M, Ikeda K, Sugiyama T, Tanaka S, et al
    Associations of ultrasound-based inflammation patterns with peripheral innate lymphoid cell populations, serum cytokines/chemokines, and treatment response to methotrexate in rheumatoid arthritis and spondyloarthritis.
    PLoS One. 2021;16:e0252116.
    PubMed     Abstract available

  33. LEE DH, Sheen SH, Lee DG, Jang JW, et al
    Association between ischemic stroke and seropositive rheumatoid arthritis in Korea: A nationwide longitudinal cohort study.
    PLoS One. 2021;16:e0251851.
    PubMed     Abstract available

  34. MATSUMOTO Y, Takahashi K, Sugioka Y, Inui K, et al
    Double-blinded randomized controlled trial to reveal the effects of Brazilian propolis intake on rheumatoid arthritis disease activity index; BeeDAI.
    PLoS One. 2021;16:e0252357.
    PubMed     Abstract available

  35. FRAENKEL L, Wei Z, Ramsey C, Wiedmeyer C, et al
    OPEX: Development of a novel overall patient experience measure to facilitate interpretation of comparison effectiveness studies.
    PLoS One. 2021;16:e0245598.
    PubMed     Abstract available

  36. NIK-AZIS NM, Mohd N, Mohd Fadzilah F, Mohamed Haflah NH, et al
    Rheumatoid arthritis serotype and synthetic disease-modifying anti-rheumatic drugs in patients with periodontitis: A case-control study.
    PLoS One. 2021;16:e0252859.
    PubMed     Abstract available

  37. REPAC J, Mandic M, Lunic T, Bozic B, et al
    Mining the capacity of human-associated microorganisms to trigger rheumatoid arthritis-A systematic immunoinformatics analysis of T cell epitopes.
    PLoS One. 2021;16:e0253918.
    PubMed     Abstract available

  38. KALWEIT M, Walker UA, Finckh A, Muller R, et al
    Personalized prediction of disease activity in patients with rheumatoid arthritis using an adaptive deep neural network.
    PLoS One. 2021;16:e0252289.
    PubMed     Abstract available

  39. DEYAB G, Reine TM, Vuong TT, Jenssen T, et al
    Antirheumatic treatment is associated with reduced serum Syndecan-1 in Rheumatoid Arthritis.
    PLoS One. 2021;16:e0253247.
    PubMed     Abstract available

  40. TAKESHITA A, Nishida K, Yoshida A, Nasu Y, et al
    RANKL expression in chondrocytes and its promotion by lymphotoxin-alpha in the course of cartilage destruction during rheumatoid arthritis.
    PLoS One. 2021;16:e0254268.
    PubMed     Abstract available

  41. JAYARAM M, Wang C, Wang L, Chung KC, et al
    Validating the Michigan Hand Outcomes Questionnaire in patients with rheumatoid arthritis using Rasch analysis.
    PLoS One. 2021;16:e0254984.
    PubMed     Abstract available

  42. MOON SJ, Jhun J, Ryu J, Kwon JY, et al
    The anti-arthritis effect of sulforaphane, an activator of Nrf2, is associated with inhibition of both B cell differentiation and the production of inflammatory cytokines.
    PLoS One. 2021;16:e0245986.
    PubMed     Abstract available

  43. RASKER JJ, Wolfe F, Klaver-Krol EG, Zwarts MJ, et al
    The relation of fibromyalgia and fibromyalgia symptoms to self-reported seizures.
    PLoS One. 2021;16:e0246051.
    PubMed     Abstract available

  44. MINAMINO H, Katsushima M, Hashimoto M, Fujita Y, et al
    Influence of dietary habits on depression among patients with rheumatoid arthritis: A cross-sectional study using KURAMA cohort database.
    PLoS One. 2021;16:e0255526.
    PubMed     Abstract available

  45. LIN PH, Yu SF, Chen JF, Chen YC, et al
    Risk factor analysis of fragility fractures in rheumatoid arthritis: A 3-year longitudinal, real-world, observational, cohort study.
    PLoS One. 2021;16:e0255542.
    PubMed     Abstract available

  46. KUMAR SK, Arya S, Singh A, Misra R, et al
    Patterns of T and B cell responses to Mycobacterium tuberculosis membrane-associated antigens and their relationship with disease activity in rheumatoid arthritis patients with latent tuberculosis infection.
    PLoS One. 2021;16:e0255639.
    PubMed     Abstract available

  47. TRIKHA R, Greig D, Sekimura T, Cevallos N, et al
    Active rheumatoid arthritis in a mouse model is not an independent risk factor for periprosthetic joint infection.
    PLoS One. 2021;16:e0250910.
    PubMed     Abstract available

  48. GONZALEZ-PONCE F, Gamez-Nava JI, Perez-Guerrero EE, Saldana-Cruz AM, et al
    Serum chemerin levels: A potential biomarker of joint inflammation in women with rheumatoid arthritis.
    PLoS One. 2021;16:e0255854.
    PubMed     Abstract available

  49. CHI C, Taylor KE, Quach H, Quach D, et al
    Hypomethylation mediates genetic association with the major histocompatibility complex genes in Sjogren's syndrome.
    PLoS One. 2021;16:e0248429.
    PubMed     Abstract available

  50. KHALED SAA, Mahmoud HFF
    Platelet indices parameters in the new disease activity score of rheumatoid arthritis with ankle involvement: A comparative analytic study.
    PLoS One. 2021;16:e0257200.
    PubMed     Abstract available

  51. KARYDIS A, Sandal I, Luo J, Prislovsky A, et al
    Influence of the shared epitope on the elicitation of experimental autoimmune arthritis biomarkers.
    PLoS One. 2021;16:e0250177.
    PubMed     Abstract available

  52. DIAZ-GALLO LM, Brynedal B, Westerlind H, Sandberg R, et al
    Understanding interactions between risk factors, and assessing the utility of the additive and multiplicative models through simulations.
    PLoS One. 2021;16:e0250282.
    PubMed     Abstract available

  53. TURESSON WADELL A, Barebring L, Hulander E, Gjertsson I, et al
    Effects on health-related quality of life in the randomized, controlled crossover trial ADIRA (Anti-inflammatory Diet In Rheumatoid Arthritis).
    PLoS One. 2021;16:e0258716.
    PubMed     Abstract available

  54. NAKAE K, Masui S, Yonezawa A, Hashimoto M, et al
    Potential application of measuring serum infliximab levels in rheumatoid arthritis management: A retrospective study based on KURAMA cohort data.
    PLoS One. 2021;16:e0258601.
    PubMed     Abstract available

  55. LIU W, Ma W, Liu H, Li C, et al
    Stroke risk in arthritis: A systematic review and meta-analysis of cohort studies.
    PLoS One. 2021;16:e0248564.
    PubMed     Abstract available

  56. SHIBATA K, Yoshimura A, Ikeuchi S, Ishii M, et al
    Effectiveness of drug safety measures for reducing the incidence of adverse drug reactions: Post-hoc analysis of data from all-case surveillance of iguratimod using generalized estimating equations.
    PLoS One. 2021;16:e0253513.
    PubMed     Abstract available

  57. DOS SANTOS LP, Santo RCDE, Ramis TR, Portes JKS, et al
    The effects of resistance training with blood flow restriction on muscle strength, muscle hypertrophy and functionality in patients with osteoarthritis and rheumatoid arthritis: A systematic review with meta-analysis.
    PLoS One. 2021;16:e0259574.
    PubMed     Abstract available

  58. MATSUMOTO H, Fujita Y, Asano T, Matsuoka N, et al
    Association between inflammatory cytokines and immune-checkpoint molecule in rheumatoid arthritis.
    PLoS One. 2021;16:e0260254.
    PubMed     Abstract available

  59. KAWAHITO Y, Takakubo Y, Morinobu A, Matsubara N, et al
    Patient satisfaction, preferences, expectations, characteristics, and impact of suboptimal control of rheumatoid arthritis: A subgroup analysis of Japanese patients from a large international cohort study (SENSE).
    PLoS One. 2021;16:e0259389.
    PubMed     Abstract available

  60. GVOZDJAKOVA A, Sumbalova Z, Kucharska J, Szamosova M, et al
    Platelet mitochondrial respiration and coenzyme Q10 could be used as new diagnostic strategy for mitochondrial dysfunction in rheumatoid diseases.
    PLoS One. 2021;16:e0256135.
    PubMed     Abstract available

  61. SEMBLER-MOLLER ML, Belstrom D, Locht H, Pedersen AML, et al
    Combined serum anti-SSA/Ro and salivary TRIM29 reveals promising high diagnostic accuracy in patients with primary Sjogren's syndrome.
    PLoS One. 2021;16:e0258428.
    PubMed     Abstract available

  62. MARRIE RA, Walld R, Bolton JM, Sareen J, et al
    Effect of comorbid mood and anxiety disorders on breast and cervical cancer screening in immune-mediated inflammatory disease.
    PLoS One. 2021;16:e0249809.
    PubMed     Abstract available

  63. FUJITA Y, Yago T, Asano T, Matsumoto H, et al
    Clinical relevance for circulating cold-inducible RNA-binding protein (CIRP) in patients with adult-onset Still's disease.
    PLoS One. 2021;16:e0255493.
    PubMed     Abstract available

  64. NOH ASM, Chuan TD, Khir NAM, Zin AAM, et al
    Effects of different doses of complete Freund's adjuvant on nociceptive behaviour and inflammatory parameters in polyarthritic rat model mimicking rheumatoid arthritis.
    PLoS One. 2021;16:e0260423.
    PubMed     Abstract available

  65. O'BRIEN P, Conley B, Bunzli S, Bullen J, et al
    Staying moving, staying strong: Protocol for developing culturally appropriate information for Aboriginal people with osteoarthritis, rheumatoid arthritis, lupus and gout.
    PLoS One. 2021;16:e0261670.
    PubMed     Abstract available

  66. CHENG BR, Chen JQ, Zhang XW, Gao QY, et al
    Cardiovascular safety of celecoxib in rheumatoid arthritis and osteoarthritis patients: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0261239.
    PubMed     Abstract available

  67. RUDD PA, Lim EXY, Stapledon CJM, Krishnan R, et al
    Pentosan polysulfate sodium prevents functional decline in chikungunya infected mice by modulating growth factor signalling and lymphocyte activation.
    PLoS One. 2021;16:e0255125.
    PubMed     Abstract available

  68. MIN HK, Kim SH, Park Y, Lee KA, et al
    Ultrasonographic characteristics of major salivary glands in anti-centromere antibody-positive primary Sjogren's syndrome.
    PLoS One. 2021;16:e0259519.
    PubMed     Abstract available

  69. CUI D, Mathews P, Li G, VanCourt S, et al
    Outcomes of Sjogren's versus non-Sjogren's related dry eye in a longitudinal, tertiary clinic-based sample.
    PLoS One. 2021;16:e0261241.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.